Patent for rapid heart test sets off litigation
This article was originally published in Clinica
Executive Summary
The Canadian firm Spectral Diagnostics last week received a US patent covering its blood test for rapidly assessing chest pain in the emergency room. It immediately launched a patent suit against its competitor Biosite Diagnostics, which last month received final US clearance for a rapid test for heart attacks.